Affiliation:
1. Department of Psychology, Translational Neuropharmacology Laboratory, University of Cyprus , Nicosia 2109 , Cyprus
Abstract
Abstract
Background
Emerging evidence suggests that viral infections may contribute to Alzheimer's disease (AD) onset and/or progression. However, the extent of their involvement and the mechanisms through which specific viruses increase AD susceptibility risk remain elusive.
Methods
We used an integrative systems bioinformatics approach to identify viral-mediated pathogenic mechanisms, by which Herpes Simplex Virus 1 (HSV-1), Human Cytomegalovirus (HCMV), Epstein-Barr virus (EBV), Kaposi Sarcoma-associated Herpesvirus (KSHV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Influenza A Virus (IAV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) could facilitate AD pathogenesis via virus-host protein-protein interactions (PPIs). We also explored potential synergistic pathogenic effects resulting from herpesvirus reactivation (HSV-1, HCMV, and EBV) during acute SARS-CoV-2 infection, potentially increasing AD susceptibility.
Results
Herpesviridae members (HSV-1, EBV, KSHV, HCMV) impact AD-related processes like amyloid-β (Aβ) formation, neuronal death, and autophagy. Hepatitis viruses (HBV, HCV) influence processes crucial for cellular homeostasis and dysfunction, they also affect microglia activation via virus-host PPIs. Reactivation of HCMV during SARS-CoV-2 infection could potentially foster a lethal interplay of neurodegeneration, via synergistic pathogenic effects on AD-related processes like response to unfolded protein, regulation of autophagy, response to oxidative stress, and Aβ formation.
Conclusions
These findings underscore the complex link between viral infections and AD development. Viruses impact AD-related processes through shared and distinct mechanisms, potentially influencing variations in AD susceptibility.
Funder
Infectious Diseases Society of America
Foundation
Publisher
Oxford University Press (OUP)
Reference56 articles.
1. The neuropathological diagnosis of Alzheimer’s disease;Deture;Mol Neurodegener,2019
2. Review of the advances in treatment for Alzheimer disease: strategies for combating β-amyloid protein;Folch;Neurol (Engl Ed),2018
3. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases;Migliore;Mutat Res,2009
4. Viral pathogens increase risk of neurodegenerative disease;Blackhurst;Nat Rev Neurol,2023